Page last updated: 2024-09-05

lapatinib and plumbagin

lapatinib has been researched along with plumbagin in 1 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(plumbagin)
Trials
(plumbagin)
Recent Studies (post-2010) (plumbagin)
1,9193051,4425370346

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)plumbagin (IC50)
Cytochrome P450 1A1Homo sapiens (human)2.77
Cytochrome P450 1A2Homo sapiens (human)2.46
60 kDa heat shock protein, mitochondrialHomo sapiens (human)6.3
Amine oxidase [flavin-containing] AHomo sapiens (human)3
M-phase inducer phosphatase 1Homo sapiens (human)0.7
M-phase inducer phosphatase 2Homo sapiens (human)3.1
10 kDa heat shock protein, mitochondrialHomo sapiens (human)6.3
Histone acetyltransferase p300Homo sapiens (human)2
Cytochrome P450 1B1Homo sapiens (human)6.15
Thiosulfate sulfurtransferaseHomo sapiens (human)0.06
60 kDa chaperonin Escherichia coli2.045
10 kDa chaperonin Escherichia coli2.045

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bratton, MR; Jones, FE; Klein Stevens, CL; Nguyen, TL; Sfondouris, ME; Sridhar, J; Townley, I1

Other Studies

1 other study(ies) available for lapatinib and plumbagin

ArticleYear
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
    Bioorganic & medicinal chemistry letters, 2014, Jan-01, Volume: 24, Issue:1

    Topics: Antibodies, Monoclonal, Humanized; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Structure; Quinones; Receptor, ErbB-2; Structure-Activity Relationship; Trastuzumab

2014